Mukka Proteins Ltd

Mukka Proteins Ltd announced reaffirmations and revisions to ratings across multiple instruments by both CARE Ratings Limited and CARE Ratings Ltd., alongside an assignment by BWR Ratings. CARE Ratings Limited reaffirmed its CARE A+ rating for Loan Facilities and Term Loan, and CARE A2 for Working Capital, all with a Stable outlook, alongside reaffirming CARE BBB- (single B minus) / CARE A3 for Bank Facilities and Long Term Bank Facilities, revising the outlook from Negative. CARE Ratings Ltd reaffirmed its CARE BBB-; Stable / CARE A3 ratings for Long-term / Short-term and Long-term bank facilities, also revising the outlook from Negative, and noted a revision to a Stable outlook for consolidated financials reflecting improved operating performance, while also highlighting adequate debt coverage metrics of 2.48x and 5.87x respectively, alongside an assigned BWR A1+ rating for a Short Term Bank Loan of Rs 50 crore, indicating adequate creditworthiness, and acknowledged a Rs 47 crore equity share warrant issuance in September 2026.

Mukka Proteins Limited submitted a certificate to the National Stock Exchange of India Limited and BSE Limited, received from Cameo Corporate Services Limited, confirming that no demat requests for processing were received during the quarter ended September 30, 2026, as no shares of the company are held in physical mode.

Mukka Proteins Limited informed the National Stock Exchange of India Limited and BSE Limited that the completion of its planned acquisition of a 51% stake in Aqua Marine, a partnership firm, will be delayed until January 31, 2027, from the previously expected date of September 30, 2026, due to procedural issues; the acquisition, initially announced on June 12, 2026, will involve a capital contribution not exceeding Rs 15,00,00,000.

Mukka Proteins Limited will close its trading window for securities transactions from October 1, 2026, until 48 hours after the announcement of its financial results for the quarter and half year ending September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Mukka Proteins Limited announced the allotment of 20,00,000 convertible warrants on a preferential basis to 15 non-promoter investors for a total consideration of Rs 47 crore. The warrants were issued at a price of Rs 23.50 per warrant, with investors paying an upfront subscription amount of Rs 5.88 per warrant, according to a regulatory filing. Each warrant allows the holder to subscribe for one equity share within 18 months.

Mukka Proteins Limited announced that its board approved a strategic investment of up to Rs 13,19,40,000 in Shipwaves Online Limited, a digital freight forwarding and enterprise SaaS solutions provider, acquiring 2,93,20,000 equity shares at Rs 4.50 per share, resulting in a 16.77% stake. The acquisition, expected to be completed by March 31, 2027, is considered a related party transaction as Mukka Proteins Limited is a promoter group entity of Shipwaves Online Limited, and is intended to leverage potential business synergies in logistics.

Mukka Proteins Ltd share price slipped 1% to Rs 23.79 after the company's net profit dropped 12.78% to Rs 18.63 crore, while revenue from operations gained significantly 29.05% to Rs 474.8 crore in Q2FY26 over Q1FY26. The market capitalization of Animal Feed industry group stocks on BSE stood at Rs 30763.81 crore, jumping 21.78%. It has softened by 3.54% over last one week and tumbled 21.98% in last one month while the market capitalization of Mukka Proteins Ltd has marginally improved by 3.93% and 0.67% in the same period respectively. Profit before tax (PBT) of Mukka Proteins Ltd stood at Rs 27.37 crore in Q2 FY26, expanding by 1059.75% year-on-year, and declining 5.26% quarter-on-quarter. EBITDA came in at Rs 46 crore, surging by 286.91% YoY and rallying 148.34% sequentially. Total expenses surged 26.88% to Rs 446.47 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 391.98 crore, posting a minor increase of 4.40% YoY, while employee benefits expense was at Rs 16.34 crore, soaring 24.45% YoY. For the TTM ended FY26, revenue from operations slumped by 26.98% to Rs 980.03 crore, while net profit tumbled by 35.27% to Rs 48.1 crore, compared to previous TTM. EBITDA surged by 8936% to Rs 79.76 crore, and PBT plunged by 31.09% to Rs 60.27 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 111.93 crore in FY26, as against Rs 150.41 crore in FY25. Mukka Proteins Ltd nosedived by 11.95% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.04% during the same period.

Mukka Proteins Limited announced that its board approved the re-appointment of Karkala Shankar Balachandra Rao, Hamad Bava, and Narendra Surendra Kamath as Non-Executive Independent Directors for a second term of five years, commencing January 15, 2027, and ending January 14, 2032, subject to shareholder approval. Additionally, the board re-appointed Kalandan Mohammed Haris as Managing Director and Chief Executive Officer for a further five years, effective January 20, 2027, to January 19, 2032, and re-appointed Kalandan Mohammed Althaf as Whole-Time Director and Chief Financial Officer and Kalandan Mohammad Arif as Whole-Time Director and Chief Operating Officer, both for five-year terms starting January 20, 2027.

Mukka Proteins Limited announced that its board approved a strategic investment of up to Rs 64,92,500 to acquire a 25.98% stake in Swachha Eco Solutions Private Limited, which is involved in the collection, treatment, and disposal of all types of waste, with the acquisition expected to be completed by December 31, 2026.

Mukka Proteins Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and three months period ended June 30, 2026, according to a regulatory filing. The trading window for dealing in the company's securities will be closed from Wednesday, July 1, 2026, until 48 hours after the results are declared for designated persons and their immediate relatives.